-
公开(公告)号:US20180219257A1
公开(公告)日:2018-08-02
申请号:US15878783
申请日:2018-01-24
Applicant: Industrial Technology Research Institute
Inventor: Lee-May Huang , Chih-Hung Chen
IPC: H01M10/0567 , H01M10/054 , H01M10/0568 , H01M10/0569 , H01M4/133 , H01M4/46 , H01M4/66 , H01M4/587 , H01M2/16
CPC classification number: H01M10/0567 , H01M2/1613 , H01M2/1626 , H01M2/1653 , H01M2/1686 , H01M4/133 , H01M4/134 , H01M4/463 , H01M4/587 , H01M4/661 , H01M4/663 , H01M10/054 , H01M10/0568 , H01M10/0569 , H01M2300/0022 , H01M2300/0028 , H01M2300/0031 , H01M2300/0045
Abstract: An aluminum-ion battery is provided. The aluminum-ion battery includes a positive electrode, a separator, a negative electrode, and an electrolyte composition. The negative electrode is separated from the positive electrode by a separator. The electrolyte composition is disposed between the positive electrode and the negative electrode. The electrolyte composition includes an aluminum halide, a solvent and a compound of Formula (I) wherein R1 is C1-8 alkyl group or C1-8 fluoroalkyl group; and n is 2, 3, 4, or 5. The sum of the aluminum halide and the solvent is 100 parts by weight. The compound of Formula (I) has a weight that is equal to or greater than 0.5 parts by weight and less than 5 parts by weight.
-
公开(公告)号:US20230203474A1
公开(公告)日:2023-06-29
申请号:US18088628
申请日:2022-12-26
Applicant: Industrial Technology Research Institute
Inventor: Ming-Chun Lin , Hui-Ling Cheng , Chun-Ting Lai , Hua-Cheng Chou , Wei-Chin Huang , Chih-Hung Chen , Shu-Feng Chen
IPC: C12N15/10 , C07H21/00 , C07D491/18 , C07H1/06
CPC classification number: C12N15/1006 , C07D491/18 , C07H1/06 , C07H21/00
Abstract: A compound, a solid carrier including the same and a method for preparing a nucleic acid are provided. The compound has a structure represented by Formula (1) as follows.
In Formula (1), the definition of Y1, Y2, Z and * are the same as defined in the detailed description.-
公开(公告)号:US11242516B2
公开(公告)日:2022-02-08
申请号:US16137925
申请日:2018-09-21
Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
Inventor: Pei-Yi Tsai , Chih-Hung Chen , Yi-Hung Lin , Chih-Chieh Huang , Hsin-Hsin Shen , Liang-Yin Ke , Chu-Huang Chen
Abstract: A method for ex vivo treating blood or plasma is provided. The method includes (a) ex vivo contacting a blood or plasma with an enzyme composition to react the enzyme composition with the blood or plasma, wherein the enzyme composition is capable of eliminating electronegative low-density lipoprotein from the blood or plasma by the activity of the enzyme composition, and the enzyme composition is selected from a group consisting of: a first enzyme for eliminating a glycan residue of an electronegative low-density lipoprotein (LDL); a second enzyme for eliminating ceramide carried by a electronegative low-density lipoprotein (LDL); and a combination thereof; and (b) terminating contact between the blood or plasma and the enzyme composition to terminate the reaction of the enzyme composition with the blood or plasma.
-
公开(公告)号:US10696638B2
公开(公告)日:2020-06-30
申请号:US16206000
申请日:2018-11-30
Applicant: Industrial Technology Research Institute
Inventor: Chih-Hung Chen , Yi-Hsun Chen , Jui-Wen Huang , Kuo-Kuei Huang , Chih-Peng Liu , Chrong-Shiong Hwang
IPC: C07D217/02 , A61K31/472 , A61P27/02 , A61K31/4725 , A61K9/08 , A61K9/00
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof is provided. In formula (I), Ar is indazole, 5-isoquinoline, 6-isoquinoline, or their N-oxide. X is —C(═Z)—, wherein Z is N—CN, NH, NR4, NCOR4, NCONR4R5, NCO-aryl, S, or O. Y and J are independently H, alkyl, aryl, aminoalkyl, —NH2, —CN, —OH, —O-alkyl, —O-aryl, —COOH, —COOR4, —CONHR4, —CONHCH2-aryl, —CONR4CH2-aryl, —NHCOR4, halogen, halogened alkyl, -alkyl-OR4, -alkyl-ONO2, alkyl-ONO2, —OCOOR4, —O(C═O)-aryl, —CHR4OH, —CH2OH, —CH2O(C═O)-aryl, —CH2O(C═O)—R4, —CHR4O(C═O)-aryl, —CHR4O(C═O)—R4, unsaturated carboxylic ester, substituted alkynyl, —NHSO2R4, —SO2R4, —SO2NHR4, or —SO2NR4R5, or Y and J bond together to form a carbocylic or aromatic ring, wherein R4 and R5 are independently H, substituted C1-C6 alkyl, substituted aryl, cycloalkyl, alkylaryl, -alkyl-NR6R7, —S(O)0-2-(alkyl-NR6R7). R1, R2 and R3 are H, C1-C6 alkyl, cycloalkyl, aryl, alkylaryl, alkylheteroaryl, alkylheterocycle, wherein any one thereof is optionally substituted with one or more of OH, NO2, or NR8R9.
-
-
-